{"id":14416,"date":"2024-07-11T15:26:01","date_gmt":"2024-07-11T19:26:01","guid":{"rendered":"https:\/\/tribu.la\/?p=14416"},"modified":"2024-07-11T15:26:06","modified_gmt":"2024-07-11T19:26:06","slug":"chiles-bybug-closes-1-4-million-seed-round","status":"publish","type":"post","link":"https:\/\/tribu.la\/pt\/chiles-bybug-closes-1-4-million-seed-round\/","title":{"rendered":"ByBug, do Chile, fecha rodada de sementes de $1,4 milh\u00e3o"},"content":{"rendered":"<p><a href=\"http:\/\/www.bybug.io.\" title=\"\">ByBug<\/a>, a Chilean biotechnology startup specializing in biomanufacturing with insects, has announced the closure of its seed funding round, raising USD 1.4 million. The round, completed in March, saw participation from <a href=\"https:\/\/sudlich.cl\/\" title=\"\">S\u00fcdlich Capital<\/a> e <a href=\"https:\/\/arpegio.vc\" title=\"\">Arpegio VC<\/a> from Chile, <a href=\"http:\/\/gridexponential.com\" title=\"\">GRIDX<\/a> from Argentina, <a href=\"https:\/\/www.halcyonventurepartners.com\/\" title=\"\">Halcyon Venture Partners<\/a>e <a href=\"https:\/\/www.atentocapital.com\/\" title=\"\">Atento Capital<\/a> from the United States.<\/p>\n\n\n\n<p>The company is focused on developing innovative solutions through the genetic editing of insects. Their technology enables the production of recombinant proteins and other sustainable bioproducts, promoting a more sustainable and efficient future in the biomanufacturing industry.<\/p>\n\n\n\n<div class=\"wp-block-fluent-crm-conditional-content\"><div class=\"fc-cond-blocks\">\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-7c1a4c1ee8bafae5d5065b126af965af\" style=\"color:#555555\"><strong>N\u00e3o perca essa chance!<\/strong> Assine nosso boletim informativo para receber o conte\u00fado mais recente diretamente em sua caixa de entrada ou <a href=\"https:\/\/tribu.la\/pt\/registro\/\" target=\"_blank\" rel=\"noreferrer noopener\">registro<\/a> GRATUITAMENTE para obter acesso total.<\/p>\n\n\n<div class='fluentform ff-default fluentform_wrapper_2  ff_guten_block ff_guten_block-2 ffs_default_wrap'><form data-form_id=\"2\" id=\"fluentform_2\" class=\"frm-fluent-form fluent_form_2 ff-el-form-top ff_form_instance_2_1 ff-form-loading ffs_default\" data-form_instance=\"ff_form_instance_2_1\" method=\"POST\" action=\"\" ><fieldset  style=\"border: none!important;margin: 0!important;padding: 0!important;background-color: transparent!important;box-shadow: none!important;outline: none!important; min-inline-size: 100%;\">\n                    <legend class=\"ff_screen_reader_title\" style=\"display: block; margin: 0!important;padding: 0!important;height: 0!important;text-indent: -999999px;width: 0!important;overflow:hidden;\">Formul\u00e1rio de assinatura<\/legend><input type='hidden' name='__fluent_form_embded_post_id' value='14416' \/><input type=\"hidden\" id=\"_fluentform_2_fluentformnonce\" name=\"_fluentform_2_fluentformnonce\" value=\"4e46de6f26\" \/><input type=\"hidden\" name=\"_wp_http_referer\" value=\"\/pt\/wp-json\/wp\/v2\/posts\/14416\" \/><div data-name=\"ff_cn_id_1\"  class='ff-t-container ff-column-container ff_columns_total_2'><div class='ff-t-cell ff-t-column-1' style='flex-basis: 65%;'><div class='ff-el-group'><div class='ff-el-input--content'><input type=\"email\" name=\"email\" id=\"ff_2_email\" class=\"ff-el-form-control\" placeholder=\"Seu e-mail\" data-name=\"email\"  aria-invalid=\"false\" aria-required=\"true\"><\/div><\/div><\/div><div class='ff-t-cell ff-t-column-2' style='flex-basis: 35%;'><div class='ff-el-group ff-text-left ff_submit_btn_wrapper ff_submit_btn_wrapper_custom'><button class=\"ff-btn ff-btn-submit ff-btn-md ff_btn_style wpf_has_custom_css\" type=\"submit\" name=\"custom_submit_button-2_1\" data-name=\"custom_submit_button-2_1\"  aria-label=\"Assine\">Assine<\/button><style>form.fluent_form_2 .wpf_has_custom_css.ff-btn-submit { background-color:rgba(0, 0, 0, 1);border-color:rgba(0, 0, 0, 1);color:#ffffff;min-width:100%; }form.fluent_form_2 .wpf_has_custom_css.ff-btn-submit:hover { background-color:#ffffff;border-color:#409EFF;color:#409EFF;min-width:100%; } <\/style><\/div><\/div><\/div><\/fieldset><input type=\"hidden\" name=\"trp-form-language\" value=\"pt\"\/><\/form><div id='fluentform_2_errors' class='ff-errors-in-stack ff_form_instance_2_1 ff-form-loading_errors ff_form_instance_2_1_errors'><\/div><\/div>            <script type=\"text\/javascript\">\n                window.fluent_form_ff_form_instance_2_1 = {\"id\":\"2\",\"settings\":{\"layout\":{\"labelPlacement\":\"top\",\"helpMessagePlacement\":\"with_label\",\"errorMessagePlacement\":\"inline\",\"asteriskPlacement\":\"\"},\"restrictions\":{\"denyEmptySubmission\":{\"enabled\":false}}},\"form_instance\":\"ff_form_instance_2_1\",\"form_id_selector\":\"fluentform_2\",\"rules\":{\"email\":{\"required\":{\"value\":true,\"message\":\"This field is required\"},\"email\":{\"value\":true,\"message\":\"This field must contain a valid email\"}}},\"debounce_time\":300};\n                            <\/script>\n            \n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<\/div><\/div>\n\n\n\n<p>Mat\u00edas Peire, CEO of GRIDX, expressed confidence in ByBug&#8217;s capabilities and ambition. &#8220;The development of a platform for producing recombinant proteins in insects is a significant endeavor. ByBug is not just addressing waste management but is also at the forefront of knowledge with the genetic editing of soldier flies.&#8221;<\/p>\n\n\n\n<p>Maxime Freyss, Fund Manager of VC at S\u00fcdlich Capital, highlighted the potential impact of the investment on the aquaculture and poultry industries. &#8220;Our investment in ByBug aims to inspire a shift towards sustainability and innovation throughout the entire food production chain.&#8221;<\/p>\n\n\n\n<p>Over the past two years, ByBug&#8217;s founding team\u2014Jos\u00e9 del Solar (CEO), Daniel Troncoso (CTO), Roc\u00edo Espinosa (COO), and Gerardo Bluske (CBO)\u2014has developed an innovative biomanufacturing method known as ByBug Synthetics. This method utilizes insects and genetic engineering to transform agricultural byproducts into recombinant proteins, such as antibodies and enzymes. These advancements have earned the trust and support of a strong group of investors.<\/p>\n\n\n\n<p>Jos\u00e9 Del Solar, CEO of ByBug, emphasized the significance of the investment: &#8220;This funding is a crucial milestone for ByBug. It will enable us to expand our R&amp;D center in Coquimbo and initiate commercial operations in Tulsa, Oklahoma, marking a significant step towards our internationalization. Our new base in the U.S. will enhance our ability to serve key clients in North America.&#8221;<\/p>\n\n\n\n<p>The funds will be used to optimize ByBug&#8217;s genetic editing technology and scale the production of recombinant proteins, which have the potential to revolutionize human and animal pharmaceuticals by reducing production costs through the use of agro-industrial byproducts. Additionally, resources will be allocated to strengthen the company&#8217;s intellectual property and establish operations in Tulsa, which will serve as a key commercial hub in North America.<\/p>","protected":false},"excerpt":{"rendered":"<p>A ByBug garante um financiamento inicial de $1,4 milh\u00f5es para expandir a fabrica\u00e7\u00e3o de produtos biol\u00f3gicos usando insetos, com foco na edi\u00e7\u00e3o gen\u00e9tica e na produ\u00e7\u00e3o sustent\u00e1vel de prote\u00ednas recombinantes.<\/p>","protected":false},"author":16,"featured_media":14742,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_vp_format_video_url":"","_vp_image_focal_point":[],"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[332,410],"tags":[629,228,321,527,299,320],"class_list":["post-14416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-tribu","tag-biomanufacturing","tag-chile","tag-funding","tag-gene-editing","tag-insects","tag-startup"],"acf":[],"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/tribu.la\/wp-content\/uploads\/2024\/07\/bybug.webp","jetpack_sharing_enabled":true,"publishpress_future_action":{"enabled":false,"date":"2026-04-23 08:17:35","action":"category","newStatus":"draft","terms":[337],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts\/14416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/comments?post=14416"}],"version-history":[{"count":1,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts\/14416\/revisions"}],"predecessor-version":[{"id":14417,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts\/14416\/revisions\/14417"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/media\/14742"}],"wp:attachment":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/media?parent=14416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/categories?post=14416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/tags?post=14416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}